Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to asess the safety and tolerability of ascending single
oral doses of PRA-027 in healthy women of nonchildbearing potential. The secondary purpose is
to provide the initial pharmacokinetic (PK) and pharmacodynamic (PD) profile of PRA-027 in
healthy women of nonchildbearing potential, and to evaluate the effect of a high-fat meal on
the PK and PD of PRA-027 administered to healthy women of nonchildbearing potential.